Download - Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK
![Page 1: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/1.jpg)
Bronchial Asthma
Dr. Shaikh Mujeeb AhmedAssistant ProfessorAlMaarefa College
IMS 423 BLOCK
![Page 2: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/2.jpg)
Intended Learning Outcomes
• Describe pathophysiology of Bronchial asthma• Enumerate the predisposing factors for
asthma• Describe the clinical features of asthma• Interpret the spirometry results lab results and
correlate with severity of the disease.
![Page 3: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/3.jpg)
EpidemiologyAccording to epidemiological studies
asthma affects 1-18% of population of different countries.
![Page 4: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/4.jpg)
What is Asthma?
• Asthma is a chronic inflammatory disease of
the airways characterized by variable recurring
symptoms,
• air flow obstruction, and
• bronchial hyper responsiveness.
![Page 5: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/5.jpg)
![Page 6: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/6.jpg)
Airway obstruction
• Episodic wheezing• Difficulty breathing, • Chest tightness, and • Cough that often is worse at night and in the
early morning.
![Page 7: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/7.jpg)
Types of Asthma
• Extrinsic – initiated by type I hypersensitivity– Atopic
• Intrinsic – Non immune mechanisms– Respiratory tract infections– Exercise, – Ingestion of aspirin,– Emotional upset, and – Exposure to bronchial irritants such as cigarette
smoke.
![Page 8: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/8.jpg)
Some allergens which may cause asthma
House-dust mites which live in carpets, mattresses and upholstered furniture
Spittle, excrements, hair and fur of domestic animals
Plant pollen
Pharmacological agents (enzymes, antibiotics, vaccines, serums)
Food components
(stabilizers, genetically modified products)
Dust of book depo-sitories
![Page 9: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/9.jpg)
Etiology & Pathogenesis
Early phase response
Late phase response
![Page 10: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/10.jpg)
Etiology & Pathogenesis
![Page 11: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/11.jpg)
Extrinsic (Atopic) Asthma
Allergen
Mast cells release inflammatory
mediators
WBCs enter region and release more
inflammatory mediators
• Type I hypersensitivity
• Mast cells’ inflammatory mediators cause acute response within 10–20 minutes
• Airway inflammation causes late phase response in 4–8 hours
![Page 12: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/12.jpg)
Role of T lymphocytes
T - Lymphocytes
TH 1 - Lymphocytes TH 2 - Lymphocytes
B - Lymphocytes B - Lymphocytes
Plasma Cells Plasma Cells
Ig G & Ig M Ig E
![Page 13: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/13.jpg)
Intrinsic (Nonatopic) Asthma
• Respiratory infections – Epithelial damage, IgE production
• Exercise, hyperventilation, cold air– Loss of heat and water may cause
bronchospasm• Inhaled irritants
– Inflammation, vagal reflex• Aspirin and other NSAIDs
– Abnormal arachidonic acid metabolism
![Page 14: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/14.jpg)
Aspirin and other NSAIDs
![Page 15: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/15.jpg)
Airway Obstruction in Asthma
inflammatory
mediatorsairway
inflammation
bronchospasm
edema
impaired
mucociliary
function
epithelial
injury
increased
airway
responsiveness
airflow limitation
![Page 16: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/16.jpg)
Pathologic anatomyMacroscopic changes:
• viscous mucous/ mucopurulent phlegm
• airway dyskinesia with zones of spastic contraction and paralytic expansion of bronchi
• obstruction of airway lumen
• lung emphysema, pneumosclerosis• RV and RA hypertrophy and dilation
![Page 17: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/17.jpg)
Microscopic changes:
• Bronchial wall infiltration with mast cells, eosinophils, basophils and T-lymphocytes
• Edema of mucous and submucous tunics • Destruction of bronchial epithelium• Hypertrophy of bronchial smooth muscles,• Hyperplasy of submucous glands • Microvessels dilation
![Page 18: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/18.jpg)
![Page 19: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/19.jpg)
Muscles
Cartilage
Gobletcells
Bronchial glands
cells Ciliated
Bronchioles (section)
![Page 20: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/20.jpg)
Muscle contraction
Mucosal edema
Mucus secretion increase
Asthma
![Page 21: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/21.jpg)
Risk Factors for Developing Asthma
• Genetic characteristics• Occupational exposures • Environmental exposures
![Page 22: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/22.jpg)
![Page 23: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/23.jpg)
Diagnosing Asthma: Medical History
• Symptoms– Coughing– Wheezing– Shortness of breath– Chest tightness
• Symptom Patterns • Severity• Family History
![Page 24: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/24.jpg)
Diagnosing Asthma
• Troublesome cough, particularly at night• Awakened by coughing• Coughing or wheezing after physical
activity• Breathing problems during particular
seasons• Coughing, wheezing, or chest tightness
after allergen exposure • Colds that last more than 10 days• Relief when medication is used
![Page 25: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/25.jpg)
Diagnosing Asthma
• Wheezing sounds during normal breathing
• Hyperexpansion of the thorax
• Increased nasal secretions or nasal polyps
• Atopic dermatitis, eczema, or other allergic skin conditions
![Page 26: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/26.jpg)
Diagnosing Asthma:Spirometry
Test lung function when diagnosing asthma
![Page 27: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/27.jpg)
Spirometry
• Measurement of • Forced expiratory volume (FEV1 )• forced vital capacity (FVC)• FEV1/VC• Peak Expiratory Flow rate (PEFR)
![Page 28: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/28.jpg)
![Page 29: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/29.jpg)
![Page 30: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/30.jpg)
Pulmonary Function Tests
![Page 31: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/31.jpg)
![Page 32: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/32.jpg)
Reversibility Test
![Page 33: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/33.jpg)
Inhalational challenge test
• Administration of sequential increasing conc. of either histamine , methacholine or mannitol.
![Page 34: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/34.jpg)
Diurnal variation in PEFR
![Page 35: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/35.jpg)
Exercise induced Asthma
![Page 36: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/36.jpg)
• Allergic skin testing• X-ray chest• Induced sputum
differential eosinophil count - >2%
• FENO
![Page 37: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/37.jpg)
Management
Asthma is extremely common and causes considerable morbidity. The aims of treatment are to:
Abolish symptoms Restore normal or best possible lung function Reduce the risk of severe attacks Enable normal growth to occur in children Minimize absence from school or employment.
![Page 38: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/38.jpg)
This involves:
• patient and family education about asthma • patient and family participation in treatment • avoidance of identified causes where possible • use of the lowest effective doses of
convenient medications to minimize short-term and long-term side-effects.
![Page 39: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/39.jpg)
Control of extrinsic factors• Measures must be taken to avoid causative
allergens such as the house-dust mite, moulds and certain food stuffs (e.g eggs ,checolate), particularly in childhood.
• Active and passive smoking should be avoided, as should beta-blockers in either tablet or eye drop form.
• Individuals intolerant to aspirin may benefit by avoiding salicylates and should avoid NSAIDs.
![Page 40: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/40.jpg)
• 50% of individuals sensitized to occupational agents may be cured if they are kept permanently away from exposure. The remaining 50% continue to have symptoms that may be as severe as when exposed to materials at work, especially if they were symptomatic for a long time before the diagnosis was made.
This emphasises: • the importance of the rapid identification of
extrinsic causes of asthma and their removal wherever possible (e.g. occupational agents, family pets)
• once extrinsic asthma is initiated, it may become self-perpetuating possibly by non-immune mechanisms.
![Page 41: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/41.jpg)
Drug treatment • The mainstay of asthma therapy is the use of
therapeutic agents delivered as aerosols or powders directly into the lungs The advantages of this method of administration are that drugs are delivered direct to the lung and the first-pass metabolism in the liver is avoided; thus lower doses are necessary and systemic unwanted effects are minimized.
• Both national and international guidelines have been published on the stepwise treatment of asthma based on three principles:
![Page 42: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/42.jpg)
1. Asthma self-management with regular asthma monitoring using peak flow meters and individual treatment plans discussed with each patient and written down.
2. The appreciation that asthma is an inflammatory disease and that anti-inflammatory (controller) therapy should be started even in mild cases.
3. Use of short-acting inhaled bronchodilators (e.g. salbutamol and terbutaline) only to relieve breakthrough symptoms. Increased use of bronchodilator treatment to relieve increasing symptoms is an indication of deteriorating disease.
![Page 43: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/43.jpg)
Drugs used in asthma• Quick relief medication
– short acting β2 agonist (salbutamol, terbutaline) – oral steroids– Anticholinergic agents
• Long-acting relief/disease controllers - Long-acting β2 agonists - salmeterol,
formoterol - Sodium cromoglicate (mast cell stabilizer)- Leukotriene modifiers• Other agents with bronchodilator activity
– Theophylline preparations
![Page 44: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/44.jpg)
• Steroid-sparing agents - Methotrexate - Ciclosporin - Gold - Intravenous immunoglobulin - Anti-IgE monoclonal antibody - Omalizumab
![Page 45: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/45.jpg)
Asthma severity classification
Clinical course, severity
Daytime asthma symptoms
Nighttime awakenings
FEV1, PEF
Intermittent< 1 /week 2 and < /month >80%
predicted. Daily variability < 20%
Mild
persistent
1 /week but not daily > 2 /month
>80% predicted. Daily variability – 20-30%
Moderate persistent
Daily > 1 /week> 60 but < 80% predicted. Variability>30%.
Severe persistent
Persistent, which limit normal activity
Daily<60% predicted. Variability > 30%.
![Page 46: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/46.jpg)
Level of Asthma control
![Page 47: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/47.jpg)
![Page 48: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/48.jpg)
![Page 49: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/49.jpg)
Managing Asthma: Peak Expiratory Flow (PEF) Meters
• Allows patient to assess status of his/her asthma
• Persons who use peak flow meters should do so frequently
• Many physicians require for all severe patients
![Page 50: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/50.jpg)
Managing Asthma: Peak Flow Chart
People with moderate or severe asthma should take readings:– Every morning– Every evening– After an
exacerbation– Before inhaling
certain medications
Source: “What You and Your Family Can Do About Asthma” by the Global Initiative For Asthma Created and funded by NIH/NHLBI
![Page 51: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/51.jpg)
A stepwise approach to the management of asthma
• Step 1: Occasional use of inhaled short-acting β2-adrenoreceptor agonist bronchodilators
• Step 2: Introduction of regular ‘preventer’ therapy• Step 3: Add-on therapy• Step 4: Poor control on moderate dose of inhaled
steroid and add-on therapy: addition of a fourth drug
• Step 5: Continuous or frequent use of oral steroids
![Page 52: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/52.jpg)
![Page 53: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/53.jpg)
Acute severe asthma
Patients with acute severe asthma typically have:
• inability to complete a sentence in one breath • respiratory rate ≥ 25 breaths per minute • tachycardia ≥ 110 beats/min (pulsus
paradoxus, is not useful as it is only present in 45% of cases)
• PEF < 50% of predicted normal or best.
![Page 54: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/54.jpg)
Features of life-threatening attacks are: • a silent chest, cyanosis or feeble respiratory
effort • exhaustion, confusion or coma • bradycardia or hypotension • PEF < 30% of predicted normal or best
(approximately 150 L/min in adults).
![Page 55: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/55.jpg)
Treatment of severe asthmaAt home • The patient is assessed. Tachycardia, a high respiratory rate
and inability to speak in sentences indicate a severe attack. • If the PEFR is less than 150 L/min (in adults), an ambulance
should be called. (All doctors should carry peak flow meters.) • Nebulized salbutamol 5 mg or terbutaline 10 mg is
administered. • Hydrocortisone sodium succinate 200 mg i.v. is given. • Oxygen 40-60% is given if available. • Prednisolone 60 mg is given orally.
![Page 56: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/56.jpg)
At hospital The patient is reassessed. Oxygen 40-60% is given. The PEFR is measured using a low-reading peak flow meter,
as an ordinary meter measures only from 60 L/min upwards.Measure O2 saturation with a pulse oximeter.
Nebulized salbutamol 5 mg or terbutaline 10 mg is repeated and administered 4-hourly.
Add nebulized ipratropium bromide 0.5 mg to nebulized salbutamol/terbutaline.
Hydrocortisone 200 mg i.v. is given 4-hourly for 24 hours.
![Page 57: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/57.jpg)
• Prednisolone is continued at 60 mg orally daily for 2 weeks. • Arterial blood gases are measured; if the Paco2 is greater than
7 kPa, ventilation should be considered. • A chest X-ray is performed to exclude pneumothorax. • One of the following intravenous infusions is given if no
improvement is seen:
– salbutamol 3-20 μg/min, or – terbutaline 1.5-5.0 μg/min, or – magnesium sulphate 1.2-2 g over 20 min.
![Page 58: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/58.jpg)
• Arterial blood gases should always be measured in asthmatic patients requiring admission to hospital. Pulse oximetry is useful in monitoring oxygen saturation during the admission and reduces the need for repeated arterial puncture. Features suggesting very severe life-threatening attacks are:
• a high Paco2 > 45 • severe hypoxaemia Pao2 < 60 despite treatment with
oxygen • a low and falling arterial pH.
![Page 59: Bronchial Asthma Dr. Shaikh Mujeeb Ahmed Assistant Professor AlMaarefa College IMS 423 BLOCK](https://reader034.vdocuments.net/reader034/viewer/2022051416/56649e405503460f94b32534/html5/thumbnails/59.jpg)
A Public Health Response to Asthma: Interventions
• Medical management• Education• Environment • Schools